Безопасный просмотр: Daiichi Sankyo

Daiichi Sankyo is a global pharmaceutical company with its corporate origin in Japan.

read more ...

The financial results for Q1 of FY2014 are now available.
read more ...

Date	Description

2014.08.07	Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination Hydrocodone Products for Pain and Opioid-Induced Nausea and Vomiting (OINV) in the US
2014.08.04	Regarding inquiries on Thursday, August 14, and Friday, August 15, 2014
2014.07.31	Daiichi Sankyo Concludes Basic Agreement for Transfer of Daiichi Sankyo Propharma Akita Plant and Decides Reorganization of Japanese Supply Chain Subsidiaries
2014.07.31	The financial results for Q1 of FY2014 are now available.
2014.07.31	Correction to the release titled "Ranbaxy Q1 FY 2015(Apr'14-Jun'14) Sales Rs.23.7 Bn"
2014.07.30	Ranbaxy Q1 FY 2015 (AprБЂ™14-JunБЂ™14) Sales Rs.23.7 Bn Growth registered in Base business profitability
2014.07.08	Notice on Details of the Share Options
2014.07.04	Marketing and Manufacturing Approval in Japan Received for CANAGLUб® Tablets 100mg
2014.07.04	Announcement on obtaining in Japan the marketing and manufacturing license for the 4-valent combination vaccine for the prevention of Pertussis, Diphtheria, Tetanus and Poliomyelitis (Polio) БЂњSquarekidsб® subcutaneous injection syringeБЂ«
2014.07.02	12th Takamine Memorial Daiichi Sankyo Prize Winner Announced